Geopolitics & Trade

A new high-tech facility in France aims to tackle the global mountain of textile waste, promising infinitely recyclable polyester and a greener future.

With its Q4 results imminent, the vitamin giant's performance in China and the US will be tested against ambitious goals and shifting global health trends.

A new report shows banks are flush with cash, but this liquidity surge is intensifying competition, squeezing profits, and forcing a high-stakes tech race.

As Global Sources announces its 2026 Vietnam fair, the event underscores the nation's pivotal role and the shift towards direct, transparent sourcing.

FDA approval for new 6- and 24-count NARCAN packs aims to streamline distribution for first responders and public health groups on the front lines.

The firm behind a controversial drug-permissive sporting event is hitting Wall Street via a SPAC, challenging the ethics of global anti-doping standards.

Home prices see modest gains, but rising incomes and balanced inventory are shifting the power back to homebuyers for the first time since the pandemic.

Cohen & Co.-backed SPAC joins the hunt for a merger target, highlighting a renewed investor appetite for blank check companies in a maturing market.

Weatherford deepens its partnership with TotalEnergies, landing a crucial multi-year deal to support Denmark's offshore energy infrastructure.

With massive data center orders but cautious guidance, the industrial giant's upcoming conference talks are a key test of investor confidence.

With a history of massive contract wins and M&A success, Bob Genter's appointment signals Peraton is doubling down on aggressive growth and operational might.

As Perimeter preps its year-end results, investors are watching if its aggressive diversification can overcome operational hurdles and justify its new shape.

Despite Q4 headwinds, the auto supplier's massive EV wins and deep focus on China fuel an ambitious 2026 forecast for double-digit profitability.

Aethlon Medical advances its Hemopurifier for oncology and Long COVID, but a shrinking cash reserve and rising quarterly loss test its lean science strategy.

The industrial giant posted strong 2025 results and a cautious 2026 outlook, banking on its execution strategy and key acquisitions in high-growth markets.

A jury verdict against Olin Corporation in a contract dispute with Shintech will cost the chemical giant $185 million and raises industry-wide questions.

The pet insurance giant swung to a major profit in 2025, but a closer look reveals a complex strategy of focused growth and rising acquisition costs.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

Brazil's fintech leader reports a record R$5.2B adjusted net income for 2025, outlining a strategy that pairs AI with human advisors to win the market.

A pioneering project in Alberta combines distributed capture with advanced MOF materials to tackle emissions from natural gas, signaling a new era for industry.